Who Supplies Meropenem? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Meropenem exports, with 401+ registered manufacturers shipping to buyers across 134+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 36.0% (export value: $80.2M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (9.8%, $21.8M). VENUS REMEDIES LIMITED (6.4%, $14.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Meropenem? Top Manufacturers & Their Buyers
Flow of Meropenem from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Meropenem Supplier Network — Key Market Intelligence
The Meropenem export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 36.0% share, shipping $80.2M worth of product across 206 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $21.8M (9.8%) to the overall market. Combined, the top two suppliers alone account for 45.8% of all Meropenem exports, indicating a relatively concentrated supply base.
Across all 401 tracked manufacturers, the total Meropenem export value stands at $222.9M from 3.7K shipments. The market average shipment value is $60.9K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM, receiving $63.2M worth of product.
The combined buyer network spans 22 named purchasing companies, including YUSEN LOGISTICS BENELUX BELGIUM, M/S. SUN PHARMA ANZ PTY LTD, M S SANKIL PHARMACEU, RANBAXY PHARMACEUTIC, EUGIA US LLC, and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Meropenem exporter from India, with a market share of 36.0% and a total export value of $80.2M across 206 shipments. Their average shipment value of $389.5K is above the market average of $60.9K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 78.8% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $63.2M across 162 shipments (78.8% of this supplier's total exports)
• M/S. SUN PHARMA ANZ PTY LTD — $15.4M across 39 shipments (19.2% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $958.5K across 2 shipments (1.2% of this supplier's total exports)
• M S SANKIL PHARMACEU — $348.7K across 1 shipments (0.4% of this supplier's total exports)
• RANBAXY PHARMACEUTIC — $313.5K across 1 shipments (0.4% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $389.5K is 539% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Meropenem exporter from India, with a market share of 9.8% and a total export value of $21.8M across 341 shipments. Their average shipment value of $64.0K is above the market average of $60.9K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. EUGIA US LLC, is the dominant customer, accounting for 53.3% of this supplier's tracked business. Top customers include:
• EUGIA US LLC, — $11.6M across 182 shipments (53.3% of this supplier's total exports)
• EUGIA US LLC, — $7.7M across 120 shipments (35.1% of this supplier's total exports)
• AUROVIDA FARMACEUTIC — $1.2M across 18 shipments (5.4% of this supplier's total exports)
• AUROBINDO PHARMA COL — $783.3K across 12 shipments (3.6% of this supplier's total exports)
• EUGIA PHARMA INDUSTR — $567.1K across 9 shipments (2.6% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $64.0K is 5% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.
3VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the third-largest Meropenem exporter from India, with a market share of 6.4% and a total export value of $14.3M across 801 shipments. Their average shipment value of $17.9K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• S T C — $4.4M across 246 shipments (30.7% of this supplier's total exports)
• E P H K — $3.6M across 202 shipments (25.2% of this supplier's total exports)
• VENUS PHARMA GMBH — $3.2M across 178 shipments (22.2% of this supplier's total exports)
• G H — $1.7M across 96 shipments (12.0% of this supplier's total exports)
• S T C SALEHIYA TRADING — $1.4M across 79 shipments (9.9% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (801 shipments) at a per-shipment value of $17.9K, indicating a broad distribution network with many smaller, regular orders.
4BROOKS STERISCIENCE LIMITED
BROOKS STERISCIENCE LIMITED is the fourth-largest Meropenem exporter from India, with a market share of 1.2% and a total export value of $2.6M across 45 shipments. Their average shipment value of $57.9K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.
BROOKS STERISCIENCE LIMITED serves 5 named buyers in our database. ARMAS PHARMACEUTICALS is the dominant customer, accounting for 74.1% of this supplier's tracked business. Top customers include:
• ARMAS PHARMACEUTICALS — $1.9M across 33 shipments (74.1% of this supplier's total exports)
• CARDINAL 3PL — $373.8K across 6 shipments (14.4% of this supplier's total exports)
• AMIPHARMA LABORATORI — $182.2K across 3 shipments (7.0% of this supplier's total exports)
• TO THE ORDER OF — $84.2K across 1 shipments (3.2% of this supplier's total exports)
• SANIMED PHARMACEUTIC — $33.7K across 1 shipments (1.3% of this supplier's total exports)
Key Insight: BROOKS STERISCIENCE LIMITED operates with high shipment frequency (45 shipments) at a per-shipment value of $57.9K, indicating a broad distribution network with many smaller, regular orders.
5VENUS REMEDIES LTD
VENUS REMEDIES LTD is the fifth-largest Meropenem exporter from India, with a market share of 1.0% and a total export value of $2.2M across 33 shipments. Their average shipment value of $67.3K is above the market average of $60.9K, suggesting premium or bulk contract pricing.
VENUS REMEDIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• S T C SALEHIYA TRADING — $1.0M across 16 shipments (47.2% of this supplier's total exports)
• VPG VENUS PHARMA GMBHAM BAHNHOF — $930.5K across 14 shipments (41.9% of this supplier's total exports)
• O S A C M S OQCORP S — $135.4K across 2 shipments (6.1% of this supplier's total exports)
• M P L M S MEDICAL PR — $57.1K across 1 shipments (2.6% of this supplier's total exports)
• PDT S A PROLIFE DE — $50.9K across 1 shipments (2.3% of this supplier's total exports)
Key Insight: VENUS REMEDIES LTD's per-shipment value of $67.3K is 11% above the market average of $60.9K, consistent with large-order contracts or value-added formulations.
6GUFIC BIOSCIENCES LIMITED
GUFIC BIOSCIENCES LIMITED is the fifth-largest Meropenem exporter from India, with a market share of 0.2% and a total export value of $400.0K across 15 shipments. Their average shipment value of $26.7K is below the market average of $60.9K, reflecting a high-volume, competitive pricing strategy.
GUFIC BIOSCIENCES LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $200.0K across 7 shipments (50.0% of this supplier's total exports)
• NA — $200.0K across 7 shipments (50.0% of this supplier's total exports)
• SLIM PHARMACEUTICALS — $48 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: GUFIC BIOSCIENCES LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $26.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Meropenem Flows
Once Meropenem leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $222.9M. Belgium absorbs the largest share at 32.0% ($71.4M), followed by United States (15.5%) and Australia (8.7%).
In Belgium — the top destination — named importers include YUSEN LOGISTICS BENELUX BELGIUM. In United States, key buyers are EUGIA US LLC,, EUGIA US LLC, AUROMEDICS PHARMA, LLC,.
This geographic spread reflects Meropenem's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Meropenem Go? Top Importing Countries & Their Buyers
Trade flow of Meropenem exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Belgium
Belgium ranks as the first-largest destination for Meropenem imports from India, with a total trade value of $71.4M across 143 shipments — representing a 32.0% share of all Meropenem exports. The average shipment value of $499.2K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Meropenem importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 97.8% ($69.8M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $69.8M (97.8% of Belgium's total)
Key Insight: Belgium's per-shipment average of $499.2K (719% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Meropenem imports from India.
2United States
United States ranks as the second-largest destination for Meropenem imports from India, with a total trade value of $34.6M across 230 shipments — representing a 15.5% share of all Meropenem exports. The average shipment value of $150.2K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.
Named Meropenem importers in United States: EUGIA US LLC, is the largest buyer, accounting for 39.9% ($13.8M) of this market's total imports.
• EUGIA US LLC, — $13.8M (39.9% of United States's total)
• EUGIA US LLC — $7.7M (22.2% of United States's total)
• AUROMEDICS PHARMA, LLC, — $5.6M (16.2% of United States's total)
Key Insight: United States's per-shipment average of $150.2K (147% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Meropenem imports from India.
3Australia
Australia ranks as the third-largest destination for Meropenem imports from India, with a total trade value of $19.4M across 7 shipments — representing a 8.7% share of all Meropenem exports. The average shipment value of $2.8M is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Meropenem importers in Australia: M/S. SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 80.1% ($15.5M) of this market's total imports.
• M/S. SUN PHARMA ANZ PTY LTD — $15.5M (80.1% of Australia's total)
Key Insight: Australia's per-shipment average of $2.8M (4445% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Meropenem imports from India.
4Germany
Germany ranks as the fourth-largest destination for Meropenem imports from India, with a total trade value of $13.3M across 159 shipments — representing a 6.0% share of all Meropenem exports. The average shipment value of $83.7K is above the global average of $60.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Meropenem importers in Germany: VENUS PHARMA GMBH is the largest buyer, accounting for 69.9% ($9.3M) of this market's total imports.
• VENUS PHARMA GMBH — $9.3M (69.9% of Germany's total)
• VPG VENUS PHARMA GMBHAM BAHNHOF — $2.2M (16.8% of Germany's total)
Key Insight: Germany's per-shipment average of $83.7K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Meropenem imports from India.
5Saudi Arabia
Saudi Arabia ranks as the fifth-largest destination for Meropenem imports from India, with a total trade value of $11.0M across 187 shipments — representing a 4.9% share of all Meropenem exports. The average shipment value of $58.9K is below the global average of $60.9K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.
Named Meropenem importers in Saudi Arabia: S T C is the largest buyer, accounting for 39.8% ($4.4M) of this market's total imports.
• S T C — $4.4M (39.8% of Saudi Arabia's total)
• SALEHIYA TRADING COMPANY — $3.8M (34.5% of Saudi Arabia's total)
• S T C SALEHIYA TRADING — $2.5M (22.3% of Saudi Arabia's total)
Key Insight: Saudi Arabia receives frequent, smaller shipments of Meropenem — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Saudi Arabia is a key market for Meropenem imports from India.
People Also Ask — Meropenem Supplier & Trade Network
Who are the top suppliers of Meropenem from India?+
Which companies buy Meropenem from Indian manufacturers?+
Where does Meropenem exported from India go?+
What is the market share of the top Meropenem supplier from India?+
What is the average shipment value for Meropenem exports from India?+
Is Meropenem manufactured in India and exported globally?+
Which country imports the most Meropenem from India?+
Who are the buyers of Meropenem in United States?+
How concentrated is the Meropenem supplier market in India?+
How do I find verified buyers for Meropenem in specific countries?+
Meropenem Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Meropenem exporter with a 36.0% market share and $80.2M in total exports — making it the single most important sourcing entity in this market.
- 2The top 401 suppliers collectively account for 54.5% of all tracked Meropenem exports, with a combined trade value of $222.9M.
- 3Belgium is the largest destination market, absorbing 32.0% of India's Meropenem exports ($71.4M). United States (15.5%) and Australia (8.7%) follow.
- 4With 3.7K total shipments averaging $60.9K each, the Meropenem export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include YUSEN LOGISTICS BENELUX BELGIUM, M/S. SUN PHARMA ANZ PTY LTD, EUGIA US LLC,, EUGIA US LLC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 134 countries
Network value: $222.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Meropenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Meropenem.
- 2.Flow Mapping: 401 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,658 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 134 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,658 Verified Shipments
401 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists